1 / 11

EPO Biomarkers Market

Global EPO Biomarkers Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

omrglobal
Download Presentation

EPO Biomarkers Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global EPO Biomarkers Market Research and Forecast 2018-2023 Healthcare Biotechnology

  2. DEFINITION Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers Market are used to increase the growth of red blood cells in the body by stimulating the bone marrow. Some of the EPO biomarkers available in the market are epoetinalfa, epoetin beta, epoetin zeta, epoetin theta, recombinant human erythropoietin, and darbepoetinalfa.  Erythropoietin alfa is used to treat anemia and cancer cells and it increases the count of red blood cells in the body. Erythropoietin is mostly administered as an alternative to iron supplements. Moreover, the erythropoietin biomarkers are used to treat end-stage renal diseases (ESRD), and anemia induced from multiple myeloma, cancer, and AIDS associated anemia.

  3. MARKET  MOTIVATORS • Increasing incidence of cancers and renal disorders • sedentary lifestyle and faulty dietary habits • increasing prevalence of chronic kidney diseases such as diabetes • upcoming patent expiration of epo biomarkers

  4. MARTET RESTRAINTS • Less of quality control testing laboratories in emerging economies

  5.  MARKET OPPORTUNITIES • Favorable healthcare regulations in emerged economies

  6. REGIONAL ANALYSIS

  7. MARKET SEGMENTATION By biomarker type • Erythropoietin alfa • Erythropoietin beta • Erythropoietin zeta • Erythropoietin theta • Recombinant human erythropoietin • Darbepoietinalfa

  8. MARKET SEGMENTATION By applications • end-stage renal disorder • cancers • rheumatoid arthritis • aids • myelodysplastic syndrome • neurology • hematology • others (anaemia of chronic inflammatory syndromes)

  9. MARKET SEGMENTATION By end users • Diagnostic centers • Ambulatory care and surgical centers • Hospitals

  10. COMPANY PROFILES • 3sbio group • agilent technologies, inc. • Amgen inc. • Bioagilytix labs • biocon To be continued…

  11. FOR MORE DETAILS PLEASE VISIT OUR WEBSITE CONTACT US Orion Market Research Pvt. Ltd. (OMR Global)116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya PradeshIndia- 452010 Global +1 646-755-7667 Asia +91 917-982-8694 info@omrglobal.com https://www.omrglobal.com 11

More Related